Thumbnail

Market Entry - Adjuvant Industry in Hong Kong: Analysis of Growth, Trends and Progress (2020 - 2025)

Looking to buy the report?

About the Market

Increase in the prevalence of cancer, growing reimbursement initiatives by governments and insurance companies covering treatment for cancer, with growth in preference for the future prevention of cancer are some of the major drivers of this market. The overall market for oncology adjuvants is classified on the basis of applications such as chemotherapy, radiotherapy, immunotherapy etc. By diseases which are treated through adjuvants, this market is classified into breast cancer, colorectal cancer, sarcoma, Hodgkin’s lymphoma, glioblastoma, lung cancer, prostate cancer, and ovarian cancer. North America, followed by Europe dominates the global market for breast cancer treatment, due to increasing incidence of cancer cases and technological advancement in the region. Some of the market players in this industry include pharmaceutical manufacturers such as Amgen Inc., Eli Lilly Co., BMS, Biogen, AstraZeneca PLC, Sanofi, and Pfizer Inc.

About the Geography

Hong Kong is a special administrative region of the People's Republic of China. It is the world’s freest and eighth largest economy. Hong Kong has no tariffs on imported goods and levies excise duty only on hydrocarbon oil, hard alcohol, tobacco, and methyl alcohol. It is the second largest recipient as well as supplier of FDI in the world. The country was ranked fifth easiest country to do business, by Doing Business.

Hong Kong acts as a bridgehead to China’s production, has an efficient banking system, favorable tax measures, excellent infrastructure, strong government, light legislations, well-educated skilled workers, and freedom of information. In 2003, Hong Kong SAR government launched CIES facilitated entry for foreign investors through investment into permissible assets, without the need to establish or join a business. Foreign companies can be set up freely, register their brands and the director of the company need not be a citizen or resident of Hong Kong. The only drawbacks are the high cost of living, elevated salaries, dependence on the financial sector, and exposure to global market risks.

With the presence of all major firms in the small region of Hong Kong, conducting business becomes very easy. Hong Kong is deemed to be the safest place to invest in the South-East Asia region.

 

Component Name

Unit

GDP (USD billion)

310

GDP Annual Growth Rate

1.7

GDP Per Capita

36117

Unemployment Rate

3.4

Wages

1940.53

Inflation Rate

4.3

Consumer Price Index (CPI)

103

Interest Rate

0.75

Loans to Private Sector (USD billion)

996.86

Balance of Trade (USD billion)

4.137

Business Confidence

-6

Manufacturing PMI (Index Points)

49.3 Index Points

Ease of Doing Business

5

Competitiveness Rank

9

Corruption Rank

18

Consumer Confidence

87

Consumer Spending (USD billion)

51.799

Bank Lending Rate (Consumers)

5

Corporate Tax Rate

16.5

 

The Market Entry Series

Exploring global markets is now recognized as the shortest way to ensure high time to efficiency conversion, when trying to expand revenues past domestic markets, for firms both large and small. Our market entry series, priced suitably low contains the essentials of all the parameters (Refer: Table of Contents) you must be apprised of before you can have a well informed contemplation of a business opportunity in your choice of industry, in your choice of geography.

Looking to buy the report?

Want some specific customizations?

Our clients include:

prev-arrow
next-arrow

Looking to Customize Report?

Please Enter Email ID

Please Enter Message